According to AstraZeneca's latest financial reports the company has $37.41 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $37.05 B | -5.67% |
2021-12-31 | $39.28 B | 151.23% |
2020-12-31 | $15.63 B | 7.14% |
2019-12-31 | $14.59 B | 3.93% |
2018-12-31 | $14.04 B | -15.61% |
2017-12-31 | $16.64 B | -0.16% |
2016-12-31 | $16.66 B | -9.94% |
2015-12-31 | $18.50 B | -5.79% |
2014-12-31 | $19.64 B | -15.51% |
2013-12-31 | $23.25 B | -2.92% |
2012-12-31 | $23.95 B | 2.04% |
2011-12-31 | $23.47 B | 0.26% |
2010-12-31 | $23.41 B | 12.43% |
2009-12-31 | $20.82 B | 29.65% |
2008-12-31 | $16.06 B | 7.68% |
2007-12-31 | $14.91 B | -3.25% |
2006-12-31 | $15.41 B | 12.6% |
2005-12-31 | $13.69 B | -5.56% |
2004-12-31 | $14.49 B | 9.35% |
2003-12-31 | $13.25 B | 18.03% |
2002-12-31 | $11.23 B | -18.39% |
2001-12-31 | $13.76 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $70.86 B | 89.41% | ๐บ๐ธ USA |
![]() Novartis NVS | $51.93 B | 38.79% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | $101.23 B | 170.57% | ๐บ๐ธ USA |
![]() Abbott Laboratories ABT | $37.23 B | -0.49% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $11.14 B | -70.20% | ๐บ๐ธ USA |
![]() Sanofi SNY | $79.27 B | 111.89% | ๐ซ๐ท France |
![]() Biogen BIIB | $14.46 B | -61.35% | ๐บ๐ธ USA |
![]() Merck MRK | $46.90 B | 25.36% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $32.03 B | -14.39% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $15.33 B | -59.01% | ๐ฌ๐ง UK |